← back to search

Rajiv Jalan

Roland Hill (United Kingdom) · GB
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Drug-Induced Hepatotoxicity and Protection, and Organ Transplantation Techniques and Outcomes.
h-index
35
citations
13,954
works
110
NIH funding
primary concept
email

Recent publications

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis
Journal of Hepatology 2021cited by 58position: middledoi
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Journal of Hepatology 2020cited by 492position: middledoi
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Journal of Hepatology 2019cited by 345position: middledoi
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
Frontiers in Immunology 2019cited by 191position: middledoi
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
Journal of Hepatology 2018cited by 368position: middledoi
Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis
Hepatology 2018cited by 120position: middledoi
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study
Quality of Life Research 2018cited by 43position: middledoi
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis
Gut 2017cited by 559position: middledoi
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study
Journal of Hepatology 2017cited by 115position: lastdoi
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure
Hepatology 2016cited by 737position: middledoi
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
Journal of Hepatology 2015cited by 859position: middledoi
Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis
Hepatology 2015cited by 623position: middledoi
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
Gut 2015cited by 572position: middledoi
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
Journal of Hepatology 2014cited by 1,022position: firstdoi
A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
Gastroenterology 2014cited by 418position: middledoi
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
Journal of Hepatology 2014cited by 361position: firstdoi
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Gastroenterology 2013cited by 2,959position: middledoi
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy
Hepatology 2013cited by 272position: middledoi
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial
Hepatology 2012cited by 557position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paolo Angeli · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo7 papers (2013–2021)Vicente Arroyo · European Foundation for the Study of Chronic Liver Failure6 papers (2013–2021)Richard Moreau · KU Leuven5 papers (2013–2021)Pere Ginès · Centre for Biomedical Network Research on Rare Diseases5 papers (2013–2017)Paolo Caraceni · Istituto delle Scienze Neurologiche di Bologna4 papers (2014–2021)François Durand · Alibaba Group (United States)4 papers (2013–2015)Mauro Bernardi · University of Bologna4 papers (2013–2015) · 4 papers (2013–2018)Alexander L. Gerbes · LMU Klinikum3 papers (2014–2015)Javier Fernández · University of Padua3 papers (2014–2021)Jonel Trebicka · Nordic Bioscience (Denmark)3 papers (2013–2021) · 3 papers (2013–2018)Wim Laleman · Vrije Universiteit Amsterdam3 papers (2013–2014)Marco Pavesi · Universitat de Barcelona3 papers (2013–2017)Thierry Gustot · University of Padua3 papers (2013–2017) · 3 papers (2013–2017) · 2 papers (2017–2018) · 2 papers (2015–2015) · 2 papers (2014–2017) · 2 papers (2015–2015)